Wan, F.; Draz, M.S.; Gu, M.; Yu, W.; Ruan, Z.; Luo, Q.
Novel Strategy to Combat Antibiotic Resistance: A Sight into the Combination of CRISPR/Cas9 and Nanoparticles. Pharmaceutics 2021, 13, 352.
https://doi.org/10.3390/pharmaceutics13030352
AMA Style
Wan F, Draz MS, Gu M, Yu W, Ruan Z, Luo Q.
Novel Strategy to Combat Antibiotic Resistance: A Sight into the Combination of CRISPR/Cas9 and Nanoparticles. Pharmaceutics. 2021; 13(3):352.
https://doi.org/10.3390/pharmaceutics13030352
Chicago/Turabian Style
Wan, Fen, Mohamed S. Draz, Mengjie Gu, Wei Yu, Zhi Ruan, and Qixia Luo.
2021. "Novel Strategy to Combat Antibiotic Resistance: A Sight into the Combination of CRISPR/Cas9 and Nanoparticles" Pharmaceutics 13, no. 3: 352.
https://doi.org/10.3390/pharmaceutics13030352
APA Style
Wan, F., Draz, M. S., Gu, M., Yu, W., Ruan, Z., & Luo, Q.
(2021). Novel Strategy to Combat Antibiotic Resistance: A Sight into the Combination of CRISPR/Cas9 and Nanoparticles. Pharmaceutics, 13(3), 352.
https://doi.org/10.3390/pharmaceutics13030352